United States · Bill · HR
H.R. 2491 (108th)
Greater Access to Affordable Pharmaceuticals Act
Introduced
17 June 2003
Last action
25 June 2003 · Referred
Status
Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Sponsors
Rep. Emerson, Jo Ann [R-MO-8], Sen. Brown, Sherrod [D-OH], Rep. Wamp, Zach [R-TN-3], Rep. Waxman, Henry A. [D-CA-33], Rep. Bono, Mary [R-CA-44], Rep. Edwards, Chet [D-TX-17], Rep. Gutknecht, Gil [R-MN-1], Rep. Emanuel, Rahm [D-IL-5], Rep. Northup, Anne M. [R-KY-3], Rep. Pallone, Frank [D-NJ-6], Rep. Bradley, Jeb [R-NH-1], Rep. Lowey, Nita M. [D-NY-17], Rep. Bereuter, Doug [R-NE-1], Rep. Serrano, Jose E. [D-NY-15], Rep. Kingston, Jack [R-GA-1], Rep. Wexler, Robert [D-FL-19], Rep. Janklow, William J. [R-SD-At Large], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Osborne, Tom [R-NE-3], Rep. Langevin, James R. [D-RI-2], Rep. Calvert, Ken [R-CA-41], Rep. Cooper, Jim [D-TN-5], Sen. Markey, Edward J. [D-MA], Rep. Allen, Thomas H. [D-ME-1], Rep. Burton, Dan [R-IN-5], Rep. Nadler, Jerrold [D-NY-12], Rep. Mollohan, Alan B. [D-WV-1], Rep. DeLauro, Rosa L. [D-CT-3], Sen. Sanders, Bernard [I-VT], Rep. Owens, Major R. [D-NY-11], Rep. Kildee, Dale E. [D-MI-5], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Smith, Nick [R-MI-7], Rep. Strickland, Ted [D-OH-6]
Subjects
Healthcare
Source updated
18 August 2025
Summary
Greater Access to Affordable Pharmaceuticals Act - Amends the Federal Food, Drug, and Cosmetic Act to: (1) limit a brand name drug manufacturer to one Food and Drug Administration (FDA) 30-month stay of competition in a patent infringement suit against a generic drug applicant; (2) permit a generic applicant being sued to file a counterclaim to correct or delete patent information; (3) limit damages that a brand name manufacturer may recover in an instance where such manufacturer failed to file certain patent information; (4) permit a generic drug applicant to seek declaratory judgment regarding patent infringement prior to marketing a drug; (5) forfeit the180-day market exclusivity period for a first generic drug applicant to a subsequent generic applicant if the first applicant engages in certain activities which impede such drug's timely marketing; and (6) permit alternative means to determine bioequivalence for drugs that are not absorbed into the bloodstream.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 June 2003
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
17 June 2003
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
17 June 2003
Introduced
Introduced in House
Source: IntroReferral
17 June 2003
Introduced
Introduced in House
Source: IntroReferral
24 June 2003
Referred
Referred to the Subcommittee on Health.
Source: Committee
25 June 2003
Referred
Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 17 June 2003 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 17 June 2003
Introduced in House (PDF)
Introduced in House · EN · 17 June 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 17 June 2003
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Emerson, Jo Ann [R-MO-8] · R · Sponsor
- Sen. Brown, Sherrod [D-OH] · D · Sponsor
- Rep. Wamp, Zach [R-TN-3] · R · Sponsor
- Rep. Waxman, Henry A. [D-CA-33] · D · Sponsor
- Rep. Bono, Mary [R-CA-44] · R · Sponsor
- Rep. Edwards, Chet [D-TX-17] · D · Sponsor
- Rep. Gutknecht, Gil [R-MN-1] · R · Sponsor
- Rep. Emanuel, Rahm [D-IL-5] · D · Sponsor
- Rep. Northup, Anne M. [R-KY-3] · R · Sponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
- Rep. Bradley, Jeb [R-NH-1] · R · Sponsor
- Rep. Lowey, Nita M. [D-NY-17] · D · Sponsor
- Rep. Bereuter, Doug [R-NE-1] · R · Sponsor
- Rep. Serrano, Jose E. [D-NY-15] · D · Sponsor
- Rep. Kingston, Jack [R-GA-1] · R · Sponsor
- Rep. Wexler, Robert [D-FL-19] · D · Sponsor
- Rep. Janklow, William J. [R-SD-At Large] · R · Sponsor
- Rep. Roybal-Allard, Lucille [D-CA-40] · D · Sponsor
- Rep. Osborne, Tom [R-NE-3] · R · Sponsor
- Rep. Langevin, James R. [D-RI-2] · D · Sponsor
- Rep. Calvert, Ken [R-CA-41] · R · Sponsor
- Rep. Cooper, Jim [D-TN-5] · D · Sponsor
- Sen. Markey, Edward J. [D-MA] · D · Sponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Sponsor
- Rep. Burton, Dan [R-IN-5] · R · Sponsor
- Rep. Nadler, Jerrold [D-NY-12] · D · Cosponsor
- Rep. Mollohan, Alan B. [D-WV-1] · D · Cosponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Cosponsor
- Sen. Sanders, Bernard [I-VT] · I · Cosponsor
- Rep. Owens, Major R. [D-NY-11] · D · Cosponsor
- Rep. Kildee, Dale E. [D-MI-5] · D · Cosponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Cosponsor
- Rep. Smith, Nick [R-MI-7] · R · Cosponsor
- Rep. Strickland, Ted [D-OH-6] · D · Cosponsor
- · hsju00 · Standing
- · hsif00 · Standing
Related records
- related to ← Greater Access to Affordable Pharmaceuticals Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/house-bill/2491
- Open data entity: https://api.congress.gov/v3/bill/108/hr/2491
- us · 108-hr-2491 · source updated 18 August 2025